Primer: Solvonis Therapeutics (SVNS LN) - Aug 2026
Solvonis is a clinical-stage biopharmaceutical company focused on high-burden Central Nervous System (CNS) disorders, with lead programs in...
93 Views
𝛼SK or SearchENTITY
Solvonis Therapeutics (SVNS LN)
Solvonis Therapeutics (SVNS LN)
7
Analysis
Industrials • United Kingdom
Solvonis Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines for high-burden central nervous system (CNS) disorders, with an initial focus on addiction and mental health. The company is advancing a pipeline of repurposed and novel compounds, including lead programs addressing Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD). Headquartered in London, United Kingdom, the company was founded in 2017.
morex